ClinicalTrials.Veeva

Menu

Reproducibility Study of Overactive Bladder Symptom Score [OABSS] (RESORT-1)

Astellas logo

Astellas

Status

Completed

Conditions

Overactive Bladder

Study type

Observational

Funder types

Industry

Identifiers

NCT01122550
EQL-CRU.004-2009

Details and patient eligibility

About

The purpose of this study is to evaluate its reproducibility of overactive bladder symptom score (OABSS) and to evaluate its correlation to other measures of OAB symptoms.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Symptoms OAB for 3 months or longer

  • At least 1 urgency episode in last 3 days

  • Symptoms of OAB as verified by 3-day micturition diary prior to Visit 1, defined by:

    • Number of micturition per day ≥8
    • Number of urgency episodes in 3 days ≥1

Exclusion criteria

  • Significant stress incontinence or mixed stress/urge incontinence
  • Subjects with indwelling catheters or practicing intermittent self-catheterization
  • Symptomatic urinary tract infection, chronic inflammation
  • Diabetic neuropathy
  • Drug or non-drug treatment for OAB was started, quitted or changed in 4 weeks
  • Participation in any clinical trial in 30 days

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems